Publications 2019-2020

Global inequities in hepatitis B and C genomic surveillance revealed through an interactive data integration dashboard

Tshiabuila D. et al, (2026), Public Health, 257, 106338 - 106338

A changing HIV treatment landscape: what does lenacapavir mean for people living with HBV?

Matthews PC. et al, (2026), Lancet Gastroenterology and Hepatology, 11, 542 - 543

Cochrane Database of Systematic Reviews

(2026)

CMV viraemia is associated with mortality among children with HIV starting antiretroviral therapy in sub-Saharan Africa

Fisayo T. et al, (2026), Clinical Infectious Diseases

Deep immune profiling of endometrial and peripheral blood cells in endometriosis

Kisovar A. et al, (2026), Human Reproduction

Intravenous Artesunate in Artemisinin-Resistant Severe Malaria in Uganda

Maitland K. et al, (2026), New England Journal of Medicine

Emergency Department Opt‐Out Testing for Hepatitis B: A Two‐Year UK Multicentre Evaluation of Outcomes Across Seven Sites

Plunkett JJ. et al, (2026), Liver International, 46

Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults—A Pilot Study

Alsaleh G. et al, (2026), Aging Cell, 25

Research without borders: advancing equitable global partnerships to accelerate HBV elimination efforts

Batbold E. et al, (2026), Nature Reviews Gastroenterology & Hepatology, 23, 454 - 456

Generative artificial intelligence for patient education material on gastric cancer prevention

Rizkala T. et al, (2026), Endoscopy, 58, 669 - 677

Patterns of testing and the high burden of iron deficiency anemia in cirrhosis: a national cohort study

Maynard S. et al, (2026), Blood Red Cells & Iron, 2, 100070 - 100070

Ensuring continued access to essential inhaled respiratory medications: a call to action from the Inhaled Respiratory medicine Innovation and environmental Sustainability (IRIS) group

Hurst JR. et al, (2026), European Respiratory Journal, 67, 2501873 - 2501873

The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategies

Strain R. et al, (2026), Hepatology, 83, 1540 - 1556

Outperformed by enzymes: why saline lavage falls short of intrapleural enzyme therapy in pleural infection.

Lee YCG. and Rahman NM., (2026), The European respiratory journal, 67

An antibiotic chatbot: Evaluation of a retrieval-augmented generation approach for providing guideline-based antimicrobial advice.

Eyre DW. et al, (2026), The Journal of infection, 93

Multicenter Validation of Clinical Sepsis Phenotypes.

Yoon CH. et al, (2026), JAMA network open, 9

DNA modifications of Durham Collection phages and promiscuity of GmrSD-family Type IV restriction enzyme BrxU.

Readshaw JJ. et al, (2026), Applied and environmental microbiology

From targets to real world impact: a review of models of care for chronic HBV and HCV in Europe

Picchio CA. et al, (2026), Lancet Regional Health Europe, 65

Advances in Diagnosis—Pulmonology

Stone E. et al, (2026), Journal of Thoracic Oncology, 21

MEDS — An Emerging Data Standard and Ecosystem for Health AI Research

McDermott MBA. et al, (2026), NEJM AI, 3

Impact of co-amoxiclav versus amoxicillin on the gastrointestinal microbiota in sub-Saharan children hospitalized with pneumonia

Rodriguez-Ruiz JP. et al, (2026), npj Antimicrobials and Resistance

Non-invasive Ventilation and levetiracetam for seizure prophylaxis In Children with Cerebral Malaria Trial (NOVICE-M): Phase I Trial

Maitland K. et al, (2026)

The PGD2/DP2 axis promotes pro-inflammatory responses but attenuates an antigen-presenting role of human basophils

Luo J. et al, (2026), Communications Biology

Benchmarking strain-level profiling of Escherichia coli in short-read gut metagenomes

Galbraith M. et al, (2026)

What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An umbrella review protocol

Martyn E. et al, (2026), Wellcome Open Research, 11, 285 - 285

Diagnosing and defining MASLD in people living with chronic hepatitis B

Martyn E. et al, (2026), Communications Medicine, 6

Eosinophil biology in COPD; from scientific insight to clinical treatment action

Cass SP. and Bafadhel M., (2026), ERJ Open Research, 01301 - 2025

Less is More: last observations of vital signs can outperform time series for hospital mortality prediction

Zhang Z. et al, (2026)

Tissue-adapted NK cells shape pathogenic cDC1 niches in early arthritis

Knight OC. et al, (2026)

Explaining variation in antibiotic prescribing for common infections: a three-way variance decomposition using UK primary care data

Nguyen NV. et al, (2026)

AMRgen: an R package for antimicrobial resistance genotype-phenotype analysis

Holt KE. et al, (2026)

After the escalator: narrative review of biomarker-guided asthma care

Gronnier M. et al, (2026), Annals of Allergy, Asthma & Immunology

Decentralised clinical trials of investigational medicinal products

Douiri A. et al, (2026), Drug Discovery Today, 31, 104676 - 104676

Commentary on the 2024 British Thoracic Society Specialty Trainee Survey report

Russell REK., (2026), Thorax, 81, 410 - 411

Elimination in the age of retrenchment: what hepatitis reveals about the future of global health

Trudeau NM. et al, (2026), The Lancet Global Health, 103959 - 103959

Anatomic Relationship Between the Greater Occipital Nerve and the Axis: Is It Possible to Safely Insert a Percutaneous C2 Screw Without Causing Occipital Neuralgia?

Khadanovich A. et al, (2026), Operative Neurosurgery, 30, 755 - 759

British Thoracic Society Quality Standard for Pleural Disease

Roberts ME. et al, (2026), BMJ Open Respiratory Research, 13, e003760 - e003760

Trends in pneumothorax mortality in England (2004–2023): a population-based observational study

Zhong X. et al, (2026), The Lancet Regional Health - Europe, 64, 101632 - 101632

Rapid diagnosis of common, undetected, and uncultivable bloodstream infections from positive blood cultures using Oxford Nanopore sequencing: a metagenomic pipeline analysis

Govender KN. et al, (2026), The Lancet Microbe, 101333 - 101333

Economic evaluation of alternative hepatitis C treatment options: a post hoc analysis of the VIETNARMS trial

Turner HC. et al, (2026), eClinicalMedicine, 95, 103969 - 103969

Nirmatrelvir–ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022–23: virological and immunological results of an open-label randomised trial (PANORAMIC)

Lowe DM. et al, (2026), The Lancet Microbe, 7, 101360 - 101360

Cutaneous Manifestations of Vasculitis: A Cross-Sectional Analysis From an International Cohort.

Micheletti RG. et al, (2026), International journal of dermatology

Viral mimicry redirects immunosuppressed colorectal tumour landscapes towards a proinflammatory and CMS1-like regenerative state.

Corry SM. et al, (2026), Communications biology

Outcomes of radiologically diagnosed solitary fibrous tumours of the pleura.

Ellayeh M. et al, (2026), ERJ open research, 12, 1018 - 2025

Cryobiopsy vs Forceps for Bronchoscopic Lung Biopsy: The FROSTBITE-2 Randomized Clinical Trial.

Thiboutot J. et al, (2026), JAMA

Improving palliative care in the UK.

Wee B. and Paes P., (2026), BMJ (Clinical research ed.), 393

Early-life Wnt4 expressing colon stromal cells orchestrate lifelong mucosal homeostasis via BMP-driven iNKT cell imprinting.

Lin X. et al, (2026), Nature communications

Controlled human malaria infection in adults identify combinations of merozoite antigens associated with clinical immunity.

Ogwang R. et al, (2026), Nature communications

Preschool wheeze endotypes and their association with asthma attacks and inhaled corticosteroid response.

Perikleous A. et al, (2026), ERJ open research, 12, 1183 - 2025

Risk Factors for Antimicrobial Resistance in Cancer Patients and Cancer Survivors: An Electronic Health Record Study

Hu F. et al, (2026)

Cookies on this website

In this section

Publications 2019-2020